Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT06022029

Conditions
Bites and Stings, Bladder Cancer, Breast Diseases, +72 more
Locations
  • California Research Institute Los Angeles, California, United States
  • BRCR Global Tamarac, Florida, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 16 locations
View Trial Details
Recruiting

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

NCT06736613

Conditions
DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, +21 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma

NCT07189065

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Anhui Cancer Hospital (West Branch of Anhui Provincial Hospital) Hefei, Anhui, China
  • Beijing Shijitan Hospital Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital Beijing, Beijing Municipality, China
  • National Cancer Center/Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
View all 41 locations
View Trial Details
Recruiting

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

NCT05602363

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +34 more
Locations
  • UC Irvine Health Orange, California, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
View all 13 locations
View Trial Details
Recruiting

Study on Plasmablastic Lymphoma Patients

NCT06781359

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • IRCCS Centro di Riferimento Oncologico di Aviano, Divisione di Oncologia e dei Tumori immuno-correlati Aviano, PN, Italy
  • Ospedale C.e G. Mazzoni, U.O.C. di Ematologia Ascoli Piceno, Italy
  • ASST Spedali Civili di Brescia, Ematologia Brescia, Italy
  • A.O. S. Croce e Carle, S.C. di Ematologia e Trapianto di Midollo Osseo Cuneo, Italy
View all 23 locations
View Trial Details

Related conditions